Switch to:
More From Other Websites
2:41 am Roche Hldg's unit Genentech reports Phase 3 study for Gazyva shows superior progression-free... Dec 06 2016
J&J Woos Billionaire Doctors Who Don’t Need Cash in Actelion Bid Dec 06 2016
Amgen/Allergan File for EU Approval of Avastin Biosimilar Dec 05 2016
Study raises questions over benefit of Roche's Gazyva cancer drug Dec 05 2016
Good Start Genetics Announces Marketing Agreement with Roche Diagnostics for Carrier Screening in... Dec 05 2016
Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly... Dec 04 2016
Merck KGaA (MKGAF) Expands Distribution Deal with Roche Dec 02 2016
Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study Dec 01 2016
Roche expands distribution alliance with the life science business of Merck KGaA, Darmstadt, Germany... Dec 01 2016
Pfizer's Herceptin biosimilar succeeds in key breast cancer study Nov 30 2016
Epizyme Tazemetostat Gets Fast Track Designation in U.S. Nov 29 2016
5 BioPharma Catalysts Expected Around Christmas Nov 27 2016
Roche launches DISCOVERY 5-Plex procedure for cancer research applications Nov 21 2016
Yes, It’s a Similar Label for Opdivo and Tecentriq in Lung Cancer Nov 21 2016
Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal Nov 18 2016
Pharma Balks at German Price Control (BAYRY, RHHBY) Nov 16 2016
Amgen Files for Avastin Biosimilar; Repatha Data Positive Nov 16 2016
Roche announces positive results for Actemra in phase III study Nov 13 2016
Phase III GiACTA Study Shows Genentech’s Actemra® is Superior to Steroids Alone in Maintaining... Nov 12 2016
Looking Abroad for Dividend Growth Nov 11 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK